New Arrhythmia Technologies
この電子書籍について
This forward-thinking book details successful trials and investigates areas of research that have not yet reached the trial phase.
The elite panel of authors have explored fresh information on:
- advances in antiarrhythmic pharmacologis therapy
- advances in monitoring, risk assessment, and noninvasive mapping
- advances in pacing therapy
- advances in implantable defibrillators
- advances in catheter and surgical ablation
- advances in antiarrhythmic biological therapy
- vision for the future of arrhythmia technologies
- web-based defibrillation monitoring.
New Arrhythmia Technologies presents a unique view of the latest in arrhythmia innovations through the eyes of the experts in the field.
著者について
Dr Paul J Wang is the Director of the Stanford Cardiac Arrhythmia Service and Cardiac Electrophysiology Laboratory. He received his undergraduate degree at Harvard University and his medical degree at Columbia University in New York City. He received his medical residency at Columbia-Presbyterian Medical Center in New York City and completed his cardiovascular training at Brigham and Women's Hospital.
Dr Wang has co-authored textbooks on implantable defibrillators, sudden cardiac death, and cardiac resynchronization/biventricular pacing therapy and has invented a number of new arrhythmia technologies.
He articipates on numerous national boards and panels in cardiac electrophysiology. He is currently Vice-Chair of the Education Committee of the Heart Rhythm Society. He is co-director of an Advanced Course in Pacemakers, Implantable Defibrillators, and Resynchronization Therapy sponsored by the Heart Rhythm Society. He also serves as a member of the Cardiac Electrophysiology Board Certification Exam Writing Committee of the American Board of Internal Medicine.
